ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Oxford Biodynamics Plc

Oxford Biodynamics Plc (OBD)

1.3625
-0.0375
(-2.68%)
Closed January 05 11:30AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
1.3625
Bid
1.205
Ask
1.52
Volume
827,828
1.15 Day's Range 1.35
0.90 52 Week Range 36.50
Market Cap
Previous Close
1.40
Open
1.35
Last Trade Time
Financial Volume
10,493p
VWAP
1.2675
Average Volume (3m)
4,873,258
Shares Outstanding
311,860,000
Dividend Yield
-
PE Ratio
-0.35
Earnings Per Share (EPS)
-0.03
Revenue
1.34M
Net Profit
-10.83M

About Oxford Biodynamics Plc

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Oxford, Gbr
Founded
-
Oxford Biodynamics Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker OBD. The last closing price for Oxford Biodynamics was 1.40p. Over the last year, Oxford Biodynamics shares have traded in a share price range of 0.90p to 36.50p.

Oxford Biodynamics currently has 311,860,000 shares outstanding. The market capitalization of Oxford Biodynamics is £4.37 million. Oxford Biodynamics has a price to earnings ratio (PE ratio) of -0.35.

OBD Latest News

Oxford BioDynamics PLC Issue of shares, Director / PDMR holdings and TVR

Oxford BioDynamics PLC 24 December 2024   Oxford BioDynamics ("OBD" or the "Company" and, together with its subsidiaries, the "Group") Issue of shares in lieu of salary, Director / PDMR...

Oxford BioDynamics PLC Shareholder Loan and Related Party Transaction

Oxford BioDynamics PLC 19 December 2024   Oxford BioDynamics ("OBD" or the "Company" and, together with its subsidiaries, the "Group")   Shareholder Loan and Related Party Transaction  ...

Oxford BioDynamics PLC Directorate Change, Funding Update & Joint Broker

Oxford BioDynamics PLC 16 December 2024   Oxford BioDynamics ("OBD" or the "Company" and, together with its subsidiaries, the "Group")   Board Changes Update on Funding Appointment of Joint...

Oxford BioDynamics PLC Holding(s) in Company

Oxford BioDynamics PLC 06 December 2024   TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft...

Oxford BioDynamics PLC Response to Share Price Movement

Oxford BioDynamics PLC 03 December 2024   Oxford BioDynamics ("OBD" or the "Company" and, together with its subsidiaries, the "Group")   Response to Share Price Movement   Oxford, UK - 3...

Oxford BioDynamics PLC Director/PDMR Shareholding

Oxford BioDynamics PLC 29 November 2024   Oxford BioDynamics ("OBD" or the "Company" and, together with its subsidiaries, the "Group") Issue of shares in lieu of salary, Director / PDMR...

Oxford BioDynamics PLC Director / PDMR holdings and Total Voting Rights

Oxford BioDynamics PLC 28 October 2024   Oxford BioDynamics ("OBD" or the "Company" and, together with its subsidiaries, the "Group") Issue of shares in lieu of salary, Director / PDMR...

Oxford BioDynamics PLC Prognostic Covid Severity Test Study Published

Oxford BioDynamics PLC 25 October 2024   Oxford BioDynamics ("OBD" or the "Company" and, together with its subsidiaries, the "Group") EpiSwitch Prognostic Covid Severity Test Study Published...

Oxford BioDynamics PLC CiRT Receives Clinical Approval from NYS CLEP

Oxford BioDynamics PLC 22 October 2024   Oxford BioDynamics ("OBD" or the "Company" and, together with its subsidiaries, the "Group") EpiSwitch® CiRT Receives Clinical Approval from  New York...

Oxford BioDynamics PLC Holding(s) in Company

Oxford BioDynamics PLC 15 October 2024     TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.00750.5535055350551.3551.51.1512526171.41433827DE
40.157513.07053941911.2051.50.916450631.1862772DE
12-2.5375-65.06410256413.93.90.948732581.30727819DE
26-6.6375-82.9687588.40.928976652.1301038DE
52-26.2375-95.063405797127.636.50.918886764.74264932DE
156-38.0375-96.541878172639.4510.997776412.54395772DE
260-112.6375-98.80482456141141250.963259716.80805093DE

OBD - Frequently Asked Questions (FAQ)

What is the current Oxford Biodynamics share price?
The current share price of Oxford Biodynamics is 1.3625p
How many Oxford Biodynamics shares are in issue?
Oxford Biodynamics has 311,860,000 shares in issue
What is the market cap of Oxford Biodynamics?
The market capitalisation of Oxford Biodynamics is GBP 4.37M
What is the 1 year trading range for Oxford Biodynamics share price?
Oxford Biodynamics has traded in the range of 0.90p to 36.50p during the past year
What is the PE ratio of Oxford Biodynamics?
The price to earnings ratio of Oxford Biodynamics is -0.35
What is the cash to sales ratio of Oxford Biodynamics?
The cash to sales ratio of Oxford Biodynamics is 2.79
What is the reporting currency for Oxford Biodynamics?
Oxford Biodynamics reports financial results in GBP
What is the latest annual turnover for Oxford Biodynamics?
The latest annual turnover of Oxford Biodynamics is GBP 1.34M
What is the latest annual profit for Oxford Biodynamics?
The latest annual profit of Oxford Biodynamics is GBP -10.83M
What is the registered address of Oxford Biodynamics?
The registered address for Oxford Biodynamics is 3140 ROWAN PLACE, JOHN SMITH DRIVE, OXFORD BUSINESS PARK SOUTH, OXFORD, OX4 2WB
What is the Oxford Biodynamics website address?
The website address for Oxford Biodynamics is www.oxfordbiodynamics.com
Which industry sector does Oxford Biodynamics operate in?
Oxford Biodynamics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TCFTheracryf Plc
0.725p
(38.10%)
7.56M
NMTNeometals Ltd
3.50p
(27.27%)
346.81k
SCHOScholium Group Plc
44.00p
(25.71%)
30.65k
FABFusion Antibodies Plc
10.15p
(24.54%)
3.34M
PYXPyx Resources Limited
3.49p
(22.24%)
8.43k
TM1Technology Minerals Plc
0.125p
(-24.24%)
37.21M
QUIZQuiz Plc
0.70p
(-18.60%)
3.67M
SYMESupply@me Capital Plc
0.003p
(-17.81%)
168.35M
OBDOxford Biodynamics Plc
1.20p
(-14.29%)
827.83k
ZENZenith Energy Ltd.
5.25p
(-13.93%)
5.39M
TRPTower Resources Plc
0.0395p
(5.33%)
539.51M
CPXCap-xx Limited
0.1825p
(1.39%)
494M
NTVONativo Resources Plc
0.0019p
(0.00%)
320.16M
DGIDg Innovate Plc
0.0225p
(-13.46%)
208.21M
ENETEthernity Networks Ltd
0.1125p
(2.27%)
207.56M

Discussion

View Full Feed
researcher59 researcher59 3 minutes ago
Thanks, SSK - it's always interesting to see all the stock picks.
capgain capgain 4 minutes ago
GL with that one too. I'm doing well so far, it's going to be a long day and evening though. I'm favored to win it, but I don't count on anything until it's over. We both have top players in tonight's game.
davidsson10 davidsson10 5 minutes ago
Beat the Seasonal Sickness Blues

https://www.eatingwell.com/new-anti-inflammatory-recipes-for-january-8768541
DMC8 DMC8 8 minutes ago
https://stocktwits.com/SanDiegoLiving/message/598858333
AMRN
capgain capgain 9 minutes ago
Amen. Stay inside and toasty, Larry.
JERSEYHAWG JERSEYHAWG 10 minutes ago
A nice remembrance.

He was a really good guy.

Thanks for that.

EDIT: s few more months. On April 3rd it will be 4 years.

How time flies and Lehman stays stagnant. Damn shame. Praying for the END. SOON.
LEHNQ
stockprofitter stockprofitter 16 minutes ago
Six fiddyyy then moon boom

15 by 20

Then Mar a Lago
Christmas 2025
FNMA
knrorrel knrorrel 17 minutes ago
QMMM or QNCCF or. OONEF !
QMMM QNCCF
cottonmather cottonmather 26 minutes ago
Tidbits: When I first saw this a couple weeks ago I thought it was BS...... Some of the best US surface to air missiles have disappeared with one reappearing at the Texas border. A large tunnel system has been made and large enough for missiles, launchers and trucks.... showing heavy traffic. Presi
cowtown jay cowtown jay 27 minutes ago
I need to push through the analysis paralysis, my unwelcomed nemesis that consumes my day doing research, and culminates with me being so overwhelmed that I don't know where to begin.

It's just so incredulous to me that the FDA can reveal their confidence in lenzilumab by granting it
dukeb dukeb 28 minutes ago
The funny thing is that there is site that is a sort of clone of iHub that allows mods to delete any post that isn't 100% rah-rah about the company. One stock I follow is down 99.8% and yet the only posts you'll see talk about how great things are going.

If stuckholders on iHub want
HMBL
baltimorebullet baltimorebullet 30 minutes ago
I assume that comparing a new drug to the SOC would be a logical step.
If you proposed a new way to purify municipal water supplies I would insist on comparing it to current practices, not just comparing it to untreated water.
AVXL
sab63090 sab63090 30 minutes ago
boi568
OK, I thought they were allowed to file when they wanted to, but that makes sense if they want to be conservative even with Dr. Jin's experience at the FDA!..I guess that might slow things down a bit; kind of like in the Army "hurry up and wait"...which happened often when we were on a
AVXL
Investor082 Investor082 32 minutes ago
Agreed. That subscription agreement will all be executed well under a dollar. Likely close to 50 cents and lower.

Why would markets value NWBO at $4-5B market cap on UK approval alone when there is no real commercialization plan, no cash to expand, and no reimbursement approval for a
NWBO
Iggy_Bot Iggy_Bot 35 minutes ago
GM, getting closer, but yet so far away.
Risk vs Reward Risk vs Reward 40 minutes ago
That would be a logical next step but I doubt they can have the necessary flight time due to power consumption? Could be wrong of course but a Tesla only get 400 miles per charge I think. 

Did you read that somewhere? Would definitely fit into ultimate stealth mode if you couldn't eve
KULR
Bull_Dolphin Bull_Dolphin 41 minutes ago
Batten down the hatches Lar, there's doozy of a storm knocking at your door.
SREZ SREZ 48 minutes ago
"As such, I expect both junior pref and common dividends to resume very soon after release."

kthomp19,
What is your updated % chance that JPS dividends are 'turned back on' (& therefore JPS presumably remain outstanding) versus being converted to either existing, or new Common?
FNMA
saskasha saskasha 51 minutes ago
Congratulations jeunke22 for explaining these evidences !
LWLG
Almosthere Almosthere 54 minutes ago
And yet you held your shares for years.

LMAO
LQMT
elks elks 59 minutes ago
Wow
TWOH
davidsson10 davidsson10 59 minutes ago
Complaining: It Ain't What It Used To Be

https://www.axios.com/2025/01/02/lawsuits-publishing-platform-lively-baldoni
Alan Brown Alan Brown 1 hour ago
How so
ARBE
dennisdave dennisdave 1 hour ago
Say, for instance, there was a rapid rise in the share price to say $3 or $5. If the $5m loan was paid,
here is a near fact that you did not include in your equitation and the same mistake is made at NWBO HQ. The SP will NOT improve drastically as long as NWBO plans to finance future operatio
NWBO